| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1953) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | B05CA04 |
| UNII: | 25W8454H16 |
| InChI Key | VACCAVUAMIDAGB-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C9H10N4O2S2 |
| Molecular Weight | 270.34 |
| AlogP | 1.23 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 97.97 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 17.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Bacterial dihydropteroate synthase inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 835603.02 | - | - | - | |
|
Enzyme
Hydrolase
|
- | - | - | - | ||
|
Enzyme
Transferase
|
- | - | - | - | 14.03 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -26.58--2.7 | |
|
Surface antigen
|
- | - | - | - | 29.3 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 100.62 | |
|
Unclassified protein
|
- | - | - | - | 29.3 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteomyelitis | 1 | D010019 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 144-82-1 |
| ChEBI | 9331 |
| ChEMBL | CHEMBL1191 |
| DrugBank | DB00576 |
| DrugCentral | 2512 |
| EPA CompTox | DTXSID5023615 |
| FDA SRS | 25W8454H16 |
| Human Metabolome Database | HMDB14715 |
| KEGG | C08050 |
| PharmGKB | PA164781307 |
| PubChem | 5328 |
| SureChEMBL | SCHEMBL26453 |
| ZINC | ZINC000000057493 |